Our interest in GBS arose from its growing interest within media outlets throughout the COVID-19 Pandemic. After learning about its possible correlation with COVID-19 vaccines (which had sparked some hesitancy within the GBS community at the time), we became curious about its pathophysiology and long-term implications. Thanks to foundations like the GBS/CIDP Foundation of Canada, we had the opportunity of learning more about GBS from experts, survivors, and long-time advocates in the field. Much like Cystinosis, GBS affects approximately 1 or 2 individuals per 100,000 every year!